Prognosis analysis of lobectomy and sublobar resection in patients ≥75 years old with pathological stage I invasive lung adenocarcinoma of ≤3 cm: a propensity score matching-based analysis

倾向得分匹配 医学 腺癌 阶段(地层学) 混淆 肺癌 病态的 解剖(医学) 外科 生存分析 比例危险模型 全肺切除术 对数秩检验 淋巴结 内科学 癌症 生物 古生物学
作者
Chunji Chen,Qiming Ni,Yubo Shi,Shijie Fu,Xufeng Pan,Yiyang Wang,Jun Yang,Rui Wang
出处
期刊:Translational cancer research [AME Publishing Company]
卷期号:8 (2): 574-582 被引量:2
标识
DOI:10.21037/tcr.2019.03.18
摘要

To determine the clinical prognosis after sublobectomy versus lobectomy in elderly patients ≥75 years old with stage I invasive lung adenocarcinoma ≤3 cm in size.In patients ≥75 years old, 255 patients were diagnosed with stage I invasive lung adenocarcinoma ≤3 cm in size between 2010 and 2014 in Shanghai Chest Hospital, they were all treated with sublobectomy or lobectomy. Potential confounding factors that consisted in the baseline characteristics of these two groups was balanced by the method of propensity score matching (PSM). The stratified analysis was conducted to compare the relapse-free survival (RFS) and lung cancer special survival (LCSS) rates in the sublobectomy and lobectomy groups.As for the 255 patients, 112 cases conducted sublobectomy and 143 with lobectomy. Significant difference existed in RFS before (P=0.002) and after (P=0.010) PSM. Similarly, we still recognized significant difference in LCSS between the two groups before (log-rank P<0.001) or after (log-rank P=0.002) PSM. We still identified different RFS or LCSS rates between the stratified tumor size group and the stratified lymph node dissection group after adjustment of PSM.Lobectomy showed a survival advantage for sublobectomy for patient ≥75 years old with stage I lung adenocarcinoma ≤3 cm in size. Considering that lobectomy could get a better prognosis, it should be preferable for the treatment of patient ≥75 years old with stage I lung adenocarcinoma ≤3 cm in size.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yinwei发布了新的文献求助10
刚刚
GHJK发布了新的文献求助10
1秒前
小蘑菇应助梨懵懵采纳,获得10
1秒前
wwwwwwww发布了新的文献求助10
1秒前
星辰大海应助醉熏的书易采纳,获得10
2秒前
2秒前
SciGPT应助橘子汽水和蛋糕采纳,获得10
2秒前
zyt发布了新的文献求助10
2秒前
Arlene发布了新的文献求助10
3秒前
爆米花应助wang采纳,获得10
3秒前
桐桐应助舒适新梅采纳,获得10
4秒前
4秒前
5秒前
xiaoguoxiaoguo完成签到,获得积分10
7秒前
深情安青应助无谓采纳,获得30
7秒前
7秒前
Jim完成签到,获得积分20
7秒前
coolman冰人发布了新的文献求助10
7秒前
7秒前
flyoverstack完成签到,获得积分20
7秒前
梓鑫完成签到,获得积分10
8秒前
滴哒完成签到,获得积分10
9秒前
9秒前
9秒前
Ava应助魁梧的黑猫采纳,获得10
9秒前
科研通AI6.2应助搞怪元彤采纳,获得10
10秒前
10秒前
张张张xxx发布了新的文献求助10
11秒前
李健应助Olivia0312采纳,获得10
11秒前
wang完成签到,获得积分10
12秒前
烜66发布了新的文献求助10
12秒前
12秒前
12秒前
13秒前
未完发布了新的文献求助20
13秒前
菠萝味的金鱼完成签到,获得积分10
13秒前
Monik发布了新的文献求助10
14秒前
好心情关注了科研通微信公众号
14秒前
噜啦啦发布了新的文献求助10
16秒前
滴滴发布了新的文献求助10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6019159
求助须知:如何正确求助?哪些是违规求助? 7611726
关于积分的说明 16161197
捐赠科研通 5166855
什么是DOI,文献DOI怎么找? 2765466
邀请新用户注册赠送积分活动 1747189
关于科研通互助平台的介绍 1635490